| LINE ITEM (USD / %) | FY 2025
FILED 2025-09-27 | FY 2024
FILED 2024-09-28 | FY 2023
FILED 2023-09-30 |
|---|---|---|---|
| Revenue (Total Sales) | $94.42B | $91.36B | $88.90B |
| YoY Revenue Growth % | +3.4% | +2.8% | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $17.55B | $15.60B | $12.86B |
| Operating Margin % | 18.6% | 17.1% | 14.5% |
| Net Income (GAAP) | $12.40B | $4.97B | $2.35B |
| EBITDA (Normalized) | $23.97B | $19.93B | $16.06B |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $18.10B | $13.97B | $9.87B |
| Capital Expenditures (CapEx) | $8.02B | $5.41B | $4.00B |
| Free Cash Flow (FCF) | $10.08B | $8.56B | $5.87B |
| FCF Margin % | 10.7% | 9.4% | 6.6% |
| Return on Invested Capital (ROIC %) | 10.0% | 9.1% | 15.8% |
| Cash & Short-Term Equivalents | $5.68B | $5.49B | — |
| Total Debt (Short + Long Term) | $35.82B | $38.69B | $24.96B |
| Total Stockholders' Equity | $108.48B | $101.93B | $51.21B |